No benefit from the obesity paradox for diabetic patients with heart failure

European Journal of Heart Failure

Volumn 18, Issue 7, 2016, Pages 851-858

  Zamora, Elisabet ^a,b   Lupón, Josep ^a,b   Enjuanes, Cristina ^c   Pascual Figal, Domingo ^d   de Antonio, Marta ^a   Domingo, Mar ^a   Comín Colet, Josep ^c   Vila, Joan ^c,e   Peñafiel, Judith ^c,e   Farré, Núria ^c   Alonso, Núria ^a,b   Santesmases, Javier ^a   Troya, Maribel ^a   Bayés Genís, Antoni ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITY OF MURCIA   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Body mass index; Diabetes; Heart failure; Mortality

Indexed keywords

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL; UNDERWEIGHT;

EID: 84978969385     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.576     Document Type: Article

References (26)

1. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med 2002;347:305–313.
2. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH; American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898–918.
3. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008;156:13–22.
4. Gupta PP, Fonarow GC, HorwichTB. Obesity and the obesity paradox in heart failure. Can J Cardiol 2015;31:195–202.
5. Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock WF, Spinar J, van Kimmenade R, Mebazaa A; GREAT (Global Research on Acute Conditions Team) Network. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 2014;63:778–785.
6. Zamora E, Lupón J, Urrutia A, González B, Mas D, Pascual T, Domingo M, Valle V. Does body mass index influence mortality in patients with heart failure? Rev Esp Cardiol 2007;60:1127–1134.
7. Zamora E, Lupón J, Urrutia A, Bayes-Genis A. Obesity and long term prognosis in heart failure: the paradox continues. Rev Esp Cardiol 2010;63:1210–1212.
8. Zamora E, Lupón J, de Antonio M, Urrutia A, Coll R, Díez C, Altimir S, Bayés-Genís A. The obesity paradox in heart failure: is etiology a key factor? Int J Cardiol 2013;166:601–605.
9. Carnethon MR, de Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR. Association of weight status with mortality in adults with incident diabetes. JAMA 2012;308:581–590.
10. Tobias DK, Pan A, Jackson CL, O'Reilly EJ, Ding EL, Willett WC, Manson JE, Hu FB. Body-mass index and mortality among adults with incident type-2 diabetes. N Engl J Med 2014;370:233–244.
11. Carnethon MR, Rasmussen-Torvik LJ, Palaniappan L. The obesity paradox in diabetes. Curr Cardiol Rep 2014;16:446.
12. Adamopoulos C, Meyer P, Desai RV, Karatzidou K, Ovalle F, White M, Aban I, Love TE, Deedwania P, Anker SD, Ahmed A. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur Heart J 2011;13:200–206.
13. Pinho E, Lourenço P, Silva S, Laszczynska O, Leite AB, Gomes F, Pimenta J, Azevedo A, Bettencourt P. Higher BMI in heart failure patients is associated with longer survival only in the absence of diabetes. J Cardiovasc Med 2015;16:576–582.
14. Farré N, Aranyó J, Enjuanes C, Verdú-Rotellar JM, Ruiz S, Gonzalez-Robledo G, Meroño O, de Ramon M, Moliner P, Bruguera J, Comin-Colet J. Differences in neurohormonal activity partly explain the obesity paradox in patients with heart failure: The role of sympathetic activation. Int J Cardiol 2015;181:120–126.
15. Zamora E, Lupón J, Vila J, Urrutia A, de Antonio M, Sanz H, Grau M, Ara J, Bayés-Genís A. Estimated glomerular filtration rate and prognosis in heart failure: value of the modification of diet in renal disease-4, chronic kidney disease epidemiology collaboration, and Cockroft–Gault formulas. J Am Coll Cardiol 2012;59:1709–1715.
16. American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care 2015;38(Suppl 1):S8–S16.
17. Heshka S, Ruggiero A, Bray GA, Foreyt J, Kahn SE, Lewis CE, Saad M, Schwartz AV; Look AHEAD Research Group. Altered body composition in type 2 diabetes mellitus. Int J Obes (Lond) 2008;32:780–787.
18. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008;28:1039–1049.
19. Karelis AD. Metabolically healthy but obese individuals. Lancet 2008;1;372:1281–1283.
20. Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO. The obesity paradox, weight loss, and coronary disease. Am J Med 2009;122:1106–1114.
21. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006;368:666–678.
22. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, wruck LM, Rosamond WD, Chang PP, Coresh J, Virani SS, Nambi V, Bozkurt B, Ballantyne CM, Deswal A. Pre-morbid body mass index and mortality after incident heart failure. The ARIC study. J Am Coll Cardiol 2014;64:2743–2749.
23. Padwal R, McAlister FA, McMurray JJV, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A. For the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) Investigators. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 2014;38:1110–1114.
24. Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 2011;4:324–331.
25. Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Millán D, Vila N, Ibañez P, Gil MJ, Valentí V, Rotellar F, Ramírez B, Salvador J, Frühbeck G. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) 2012;36:286–294.
26. Gastelurrutia P, Lupón J, de Antonio M, Zamora E, Domingo M, Urrutia A, Altimir S, Coll R, Díez C, Bayes-Genis A. Body mass index, body fat, and nutritional status of patients with heart failure: the PLICA study. Clin Nutr 2015;34:1233–1238.